> SARS-CoV-2 SL5 NC_045512.2 150-294
UCGUUGACAGGACACGAGUAACUCGUCUAUCUUCUGCAGGCUGCUUACGGUUUCGUCCGUGUUGCAGCCGAUCAUCAGCACAUCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUCCCUGGUUUCAACGA
> SARS-CoV-1 SL5 NC_004718.3 149-293 
UCGUUGACAAGAAACGAGUAACUCGUCCCUCUUCUGCAGACUGCUUACGGUUUCGUCCGUGUUGCAGUCGAUCAUCAGCAUACCUAGGUUUCGUCCGGGUGUGACCGAAAGGUAAGAUGGAGAGCCUUGUUCUUGGUGUCAACGA
> MERS SL5 NC_019843.3 196-349
UUUUCAGUUAGAGCGUCGUGUCUCUUGUACGUCUCGGUCACAAUACACGGUUUCGUCCGGUGCGUGGCAAUUCGGGGCACAUCAUGUCUUUCGUGGCUGGUGUGACCGCGCAAGGUGCGCGCGGUACGUAUCGAGCAGCGCUCAACUCUGAAAA
> BtCoV-HKU5 SL5 NC_009020.1 178-331 
UUUUCAGUUAGAGCAUCGUGUCUCAAGUGCUUCACGGUCACAAUAUACCGUUUCGUCGGGUGCGUGGCAAUUCGGUGCACAUCAUGUCUUUCGUGGCUGGUGUGGCUCCUCAAGGUGCGAGGGGCAAGUAUAGAGCAGAGCUCAACACUGAAAA
> HCoV-229E SL5 MF542265.1 139-307
GGUUGCAACAGUUUGGAAGCAAGUGCUGUGUGUUCUAGUCUAAGGGUUUCGUGUUCCGUCACGAGAUUCCAUUCUACAAACGCCUUACGCGAGGUUCUGUCUCGUGUUUGUGUGGAAGCAAAGUUUUGUCUUUGUGGAAACCAGUAACUGUUCCUAAUGGCCUGCAACC
> HCoV-NL63 SL5 NC_005831.2 136-297 
UUGUAAACUGGUUAGGCAAGUGUUGUAUUUUCUGUGUCUAAGCACUGGUGAUUCUGUUCACUAGUGCAUACAUUGAUAUUUAAGUGGUGUUCCGUCACUGCUUAUUGUGGAAGCAACGUUCUGUCGUUGUGGAAACCAAUAACUGCUAACCAUGUUUUACAA
